Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RBR-3sg8mbcCompleted
Randomised, open-label trial of calendula officinalis extract in Not applicable (not a disease) (2 arms), sponsored by Pontifícia Universidade Católica do Paraná. Primary endpoint: Time to epithelialization. Started Feb 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on RBR-3sg8mbc.